Matches in Wikidata for { <http://www.wikidata.org/entity/Q64666305> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q64666305 description "assaig clínic" @default.
- Q64666305 description "clinical trial" @default.
- Q64666305 description "clinical trial" @default.
- Q64666305 description "clinical trial" @default.
- Q64666305 description "clinical trial" @default.
- Q64666305 description "ensaio clínico" @default.
- Q64666305 description "ensayo clínico" @default.
- Q64666305 description "ensayu clínicu" @default.
- Q64666305 description "essai clinique" @default.
- Q64666305 description "klinisch onderzoek" @default.
- Q64666305 description "клінічне випробування" @default.
- Q64666305 description "կլինիկական փորձարկում" @default.
- Q64666305 name "A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne" @default.
- Q64666305 type Item @default.
- Q64666305 label "A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne" @default.
- Q64666305 prefLabel "A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne" @default.
- Q64666305 P1132 Q64666305-6FA19757-B649-40F4-906F-7031C3FF7691 @default.
- Q64666305 P1476 Q64666305-E013618B-E8CA-4C85-BB68-DA8479B0919E @default.
- Q64666305 P17 Q64666305-2971B891-9CE4-4A0E-B024-6E0A79BBD16E @default.
- Q64666305 P17 Q64666305-98722D44-EBDA-4B00-84A6-22710BEEE341 @default.
- Q64666305 P2899 Q64666305-C32E7C7B-92C5-4663-8354-CC7A5A3373FD @default.
- Q64666305 P3098 Q64666305-E86DAF4A-671F-4E53-BEA8-FBE1860A2DBA @default.
- Q64666305 P31 Q64666305-1A015578-B31F-4867-BFA3-FA323DCF1FC7 @default.
- Q64666305 P4135 Q64666305-DDD565C2-0E3E-4089-B6AF-8B6E091561AE @default.
- Q64666305 P580 Q64666305-A2F2CC6C-64BD-4F2F-84A3-7BCE2F470424 @default.
- Q64666305 P582 Q64666305-FF3B7008-4DF6-4D9B-BA75-82C4B7398745 @default.
- Q64666305 P6099 Q64666305-3D227BBE-A286-40C9-AAAA-58AD7B3D3CCA @default.
- Q64666305 P6153 Q64666305-3D02ED79-AE0C-4354-9355-631A3FD5FFB5 @default.
- Q64666305 P6153 Q64666305-4002882E-DAB2-47CA-9DC6-0085E104F00A @default.
- Q64666305 P6153 Q64666305-AECA0A71-7046-4E7C-84B2-793898C1CBE2 @default.
- Q64666305 P6153 Q64666305-F107050C-D173-4C40-B557-83C72F9AD57D @default.
- Q64666305 P767 Q64666305-CAC30694-178D-4BC0-8202-559B4D78C9F9 @default.
- Q64666305 P8363 Q64666305-5ADAB1DB-91C2-41FF-8E75-628D468C3079 @default.
- Q64666305 P1132 "+742" @default.
- Q64666305 P1476 "A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Acne Vulgaris" @default.
- Q64666305 P17 Q16 @default.
- Q64666305 P17 Q30 @default.
- Q64666305 P2899 "+12" @default.
- Q64666305 P3098 "NCT01017120" @default.
- Q64666305 P31 Q30612 @default.
- Q64666305 P4135 "+45" @default.
- Q64666305 P580 "2009-10-01T00:00:00Z" @default.
- Q64666305 P582 "2010-11-01T00:00:00Z" @default.
- Q64666305 P6099 Q42824827 @default.
- Q64666305 P6153 Q30269960 @default.
- Q64666305 P6153 Q30270351 @default.
- Q64666305 P6153 Q30270477 @default.
- Q64666305 P6153 Q30270651 @default.
- Q64666305 P767 Q212322 @default.
- Q64666305 P8363 Q78089383 @default.